Literature DB >> 1864533

Enteropathogenic Escherichia coli and life threatening chronic diarrhoea.

S M Hill1, A D Phillips, J A Walker-Smith.   

Abstract

Enteropathogenic Escherichia coli (EPEC) infection is not generally thought to cause severe diarrhoea after the neonatal period. Patients admitted to Queen Elizabeth Hospital for Children over the three years (1984-7) with diarrhoea and EPEC infection were reviewed. Clinical details, features of small intestinal mucosa, and treatment were recorded in those who developed chronic diarrhoea with failure to thrive. Twenty six children with EPEC required hospital admission for diarrhoea and six of these (23%) developed chronic diarrhoea. In contrast only two (5%) of 42 with other serogroups of E coli (p less than 0.01) and 28 (4%) of 764 children without EPEC admitted with acute diarrhoea developed chronic symptoms (p less than 0.01). EPEC serogroups detected in the stool of the six children with chronic diarrhoea were 0128 in three, 0114 in two, and 0119 in one. The patients' clinical characteristics were: previous good health, no significant immunodeficiency, age 4-10 months, foreign travel (three of six), severe life threatening secretory diarrhoea from 0.5 to 1.5 1 per day (four of six), small intestinal enteropathy (five of six) three of whom showed mucosal adherent, non-invasive E coli of the same serotype as that in the stool, in association with microvillous loss and pedestal formation. All were treated with hypoallergenic feeds, two with parenteral nutrition, and three with parenteral antibiotics. All eventually recovered. EPEC infection is a common treatable cause of life threatening chronic diarrhoea in infancy.

Entities:  

Mesh:

Year:  1991        PMID: 1864533      PMCID: PMC1378798          DOI: 10.1136/gut.32.2.154

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

Review 1.  HEp-2 cell adherence as an assay for virulence among diarrheagenic Escherichia coli.

Authors:  J J Mathewson; A Cravioto
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

2.  Travellers' diarrhoea among children returning to the United Kingdom from visits abroad.

Authors:  A E Msengi; A D Phillips; R A Risdon; J A Walker-Smith
Journal:  Ann Trop Paediatr       Date:  1988-09

3.  Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa.

Authors:  S Knutton; D R Lloyd; A S McNeish
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

4.  Antibiotics for Escherichia coli gastroenteritis.

Authors:  S M Hill; A D Phillips; J A Walker-Smith; I R Sanderson; P J Milla
Journal:  Lancet       Date:  1988-04-02       Impact factor: 79.321

Review 5.  Bacterial diarrhoea and its treatment.

Authors:  S L Gorbach
Journal:  Lancet       Date:  1987-12-12       Impact factor: 79.321

Review 6.  Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis.

Authors:  M M Levine; R Edelman
Journal:  Epidemiol Rev       Date:  1984       Impact factor: 6.222

7.  Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine.

Authors:  J M Nightingale; E R Walker; W R Burnham; M J Farthing; J E Lennard-Jones
Journal:  Aliment Pharmacol Ther       Date:  1989-08       Impact factor: 8.171

8.  Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea.

Authors:  N S Williams; J C Cooper; A T Axon; R F King; M Barker
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-20

9.  Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  S Knutton; T Baldwin; P H Williams; A S McNeish
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive.

Authors:  M M Levine; E J Bergquist; D R Nalin; D H Waterman; R B Hornick; C R Young; S Sotman
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

View more
  33 in total

Review 1.  The immune responses to bacterial antigens encountered in vivo at mucosal surfaces.

Authors:  G Dougan; M Ghaem-Maghami; D Pickard; G Frankel; G Douce; S Clare; S Dunstan; C Simmons
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

2.  Structure-function analysis of BfpB, a secretin-like protein encoded by the bundle-forming-pilus operon of enteropathogenic Escherichia coli.

Authors:  S A Schmidt; D Bieber; S W Ramer; J Hwang; C Y Wu; G Schoolnik
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

Review 3.  Enteropathogenic Escherichia coli.

Authors:  M S Donnenberg; J B Kaper
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 4.  Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.

Authors:  Lila G Glotfelty; Gail A Hecht
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

5.  Atypical Enteropathogenic Escherichia coli: from Kittens to Humans and Beyond!

Authors:  Shantanu Bhatt
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

6.  Bundle-forming pili and EspA are involved in biofilm formation by enteropathogenic Escherichia coli.

Authors:  Cristiano G Moreira; Kelli Palmer; Marvin Whiteley; Marcelo P Sircili; Luiz R Trabulsi; Antonio F P Castro; Vanessa Sperandio
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

7.  Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.

Authors:  Mohammed A Khan; Caixia Ma; Leigh A Knodler; Yanet Valdez; Carrie M Rosenberger; Wanyin Deng; B Brett Finlay; Bruce A Vallance
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

8.  Enteropathogenic Escherichia coli markedly decreases the resting membrane potential of Caco-2 and HeLa human epithelial cells.

Authors:  M A Stein; D A Mathers; H Yan; K G Baimbridge; B B Finlay
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

9.  Attaching and effacing enteropathogenic Escherichia coli O18ab invades epithelial cells and causes persistent diarrhea.

Authors:  I C Scaletsky; M Z Pedroso; U Fagundes-Neto
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

10.  Characterisation of atypical enteropathogenic E. coli strains of clinical origin.

Authors:  Sharon M Tennant; Marija Tauschek; Kristy Azzopardi; Andrea Bigham; Vicki Bennett-Wood; Elizabeth L Hartland; Weihong Qi; Thomas S Whittam; Roy M Robins-Browne
Journal:  BMC Microbiol       Date:  2009-06-03       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.